GF Fund Management’s Tectonic Therapeutic TECX Stock Holding History

GF Fund Management’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.8K	Sell	400 -15	-4%	-$441	﹤0.01%	517
2026 Q1	$12.8K	Buy	415 +48	+13%	+$1.18K	﹤0.01%	537
2025 Q4	$7.66K	Sell	367 -36	-9%	-$669	﹤0.01%	601
2025 Q3	$6.32K	Buy	403 +26	+7%	+$537	﹤0.01%	593
2025 Q2	$7.49K	Hold	377	–	–	﹤0.01%	597
2025 Q1	$6.68K	Buy	377 +67	+22%	+$2.18K	﹤0.01%	605
2024 Q4	$14.3K	Buy	+310	New	+$13.1K	﹤0.01%	503

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

GF Fund Management's TECX Position: Q2 2026 in Review

GF Fund Management reduced its Tectonic Therapeutic (TECX) stake by 3.6% in Q2 2026, selling an estimated $441 and leaving 400 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #517.

GF Fund Management first reported a position in TECX in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.3K in Q4 2024. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

GF Fund Management held 400 shares of Tectonic Therapeutic worth $13.8K as of Q2 2026.
GF Fund Management sold 15 Tectonic Therapeutic shares in Q2 2026, an estimated $441.
Tectonic Therapeutic made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #517 holding.
GF Fund Management first reported a position in Tectonic Therapeutic in Q4 2024 and has held it in 7 quarters since.
GF Fund Management's Tectonic Therapeutic position peaked at $14.3K in Q4 2024.
123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.